Further characterization of Bacillus subtilis antibiotic biosensors and their use for antibacterial mode-of-action studies

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1784-1786

  Mariner, Katherine R ^a   Ooi, Nicola ^a   Roebuck, Deborah ^a   O'Neill, Alex J ^a   Chopra, Ian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL; ANHYDROTETRACYCLINE; ANTIBIOTIC AGENT; BAICALEIN; BORRELIDIN; CETRIMIDE; CHROMOMYCIN; CIPROFLOXACIN; CLOFAZIMINE; CORRALOPYRONIN; CYCLOSERINE; DAPTOMYCIN; DAUNORUBICIN; DEOXYACTAGARDINE B; DOXORUBICIN; FOSFOMYCIN; FOSMIDOMYCIN; HOLOMYCIN; INDOLMYCIN; JUGLONE; MYXOPYRONIN B; PSEUDOMONIC ACID; RIPOSTATIN; SEPRACOR 155342; TELAVANCIN; THIOLUTIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALINOMYCIN; XF 70; XF 73;

ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BIOSENSOR; DNA SYNTHESIS; DRUG MECHANISM; FATTY ACID SYNTHESIS; INHIBITION KINETICS; MEMBRANE DAMAGE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS;

AMINO ACYL-TRNA SYNTHETASES; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BIOSENSING TECHNIQUES; CIPROFLOXACIN; ENZYME INHIBITORS; FATTY ALCOHOLS; INDOLES; MUPIROCIN; NAPHTHOQUINONES; OXYQUINOLINE; TETRACYCLINES;

EID: 79953210747     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01710-10     Document Type: Article

References (27)

1. Behr, W., K. Honikel, and G. Hartmann. 1969. Interaction of the RNA polymerase inhibitor chromomycin with DNA. Eur. J. Biochem. 9:82-92.
2. Boakes, S., A. N. Appleyard, J. Cortes, and M. J. Dawson. 2010. Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362. J. Antibiot. 63:351-358.
3. Chao, S.-H., A. L. Greenleaf, and D. H. Price. 2001. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 29:767-773.
4. Collins, J. J., C. R. Adler, J. A. Fernandez-Pol, D. Court, and G. S. Johnson. 1979. Transient growth inhibition of Escherichia coli K-12 by ion chelators: "in vivo" inhibition of ribonucleic acid synthesis. J. Bacteriol. 138:923-932.
5. Fraser, R. S. S., and J. Creanor. 1975. The mechanism of inhibition of ribonucleic acid synthesis by 8-hydroxyquinoline and the antibiotic lomofungin. Biochem. J. 147:401-410.
6. Gale, E. F., E. Cundliffe, P. E. Reynolds, M. H. Richmond, and M. J. Waring. 1981. The molecular basis of antibiotic action, 2nd ed. John Wiley and Sons, London, United Kingdom.
7. Higgins, D. L., et al. 2005. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49:1127-1134.
8. Hobbs, J. K., K. Miller, A. J. O'Neill, and I. Chopra. 2008. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. J. Antimicrob. Chemother. 62:1003-1008.
9. Hurdle, J. G., A. J. O'Neill, and I. Chopra. 2005. Prospects for aminoacyltRNA synthetase inhibitors as new antimicrobial agents. Antimicrob. Agents Chemother. 49:4821-4833.
10. Lindner, B., A. Wiese, K. Brandenburg, U. Seydel, and A. Dalhoff. 2002. Lack of interaction of fluoroquinolones with lipopolysaccharides. Antimicrob. Agents Chemother. 46:1568-1570.
11. Mariner, K., et al. 2010. Furanyl-rhodanines: unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. Antimicrob. Agents Chemother. 54:4506-4509.
12. Mukhopadhyay, J., et al. 2008. The RNA polymerase "switch region" is a target for inhibitors. Cell 135:295-307.
13. Neu, H. C., and T. Kamimura. 1982. Synergism of fosmidomycin (FR-31564) and other antimicrobial agents. Antimicrob. Agents Chemother. 22:560-563.
14. Oliva, B., G. Gordon, P. McNicholas, G. Ellestad, and I. Chopra. 1992. Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob. Agents Chemother. 36:913-919.
15. Oliva, B., A. O'Neill, J. M. Wilson, P. J. O'Hanlon, and I. Chopra. 2001. Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob. Agents Chemother. 45:532-539.
16. Oliva, B., et al. 2003. Biological properties of novel antistaphylococcal quinoline-indole agents. Antimicrob. Agents Chemother. 47:458-466.
17. Oliva, B., A. J. O'Neill, K. Miller, W. Stubbings, and I. Chopra. 2004. Anti-staphylococcal activity and mode of action of clofaximine. J. Antimicrob. Chemother. 53:435-440.
18. Reference deleted.
19. Ono, K., and H. Nakane. 1990. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J. Biochem. 108:609-613. (Pubitemid 20336675)
20. Ooi, N., et al. 2009. XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. J. Antimicrob. Chemother. 64:735-740.
21. Ooi, N., et al. 2010. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. J. Antimicrob. Chemother. 65:72-78.
22. Oxford University Press. 1991. A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 27(Suppl. D):1-50.
23. Rasmussen, B., et al. 1991. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob. Agents Chemother. 35:2306-2311.
24. Sartiano, G. P., W. E. Lynch, and W. D. Bullington. 1979. Mechanism of action of the anthracycline anti-tumour antibiotics, doxorubicin, daunomycin and rubidazone: preferential inhibition of DNA polymerase α. J. Antibiot. 32:1038-1045.
25. Suerbaum, S., H. Leying, H.-P. Kroll, J. Gmeiner, and W. Opferkuch. 1987. Influence of β-lactam antibiotics and ciprofloxacin on cell envelope of Escherichia coli. Antimicrob. Agents Chemother. 31:1106-1110.
26. Urban, A., et al. 2007. Novel whole-cell antibiotic biosensors for compound discovery. Appl. Environ. Microbiol. 73:6436-6443.
27. Wu, F. Y.-H., and C.-W. Wu. 1973. Rose Bengal: an inhibitor of ribonucleic acid chain elongation. Biochemistry 12:4343-4348.